Response to Comments: MolDX: Genetic Testing for Heritable Thoracic Aortic Disease

This document is a response-to-comments notice for the MolDX Local Coverage Determination L39933 on genetic testing for heritable thoracic aortic disease and does not specify clinical coverage criteria. It records the comment period (8/29/2024–10/12/2024), the notice period start (7/3/2025), and the LCD effective date (8/17/2025); for actual indications, limitations, and documentation requirements, refer to the substantive LCD L39933 when available.

"This document is a response-to-comments notice for MolDX LCD L39933 (Genetic Testing for Heritable Thoracic Aortic Disease) and does not itself define coverage criteria; it records the comment peri..."

Sign up to see full coverage criteria, indications, and limitations.